Brief: Gland Pharma Gets US FDA Approval For Latanoprost Ophthalmic Solution, 0.005%
03/12/2024 07:45
Dec 3 (Reuters) - Gland Pharma Ltd GLAD.NS :
* RECEIPT OF US FDA APPROVAL FOR LATANOPROST OPHTHALMIC
SOLUTION,
0.005%
* EXPECTS TO LAUNCH THIS PRODUCT THROUGH ITS MARKETING
PARTNERS IN
FY25
Source text: ID:nNSE85dvSv
Further company coverage: GLAD.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant